Inventor · disambiguated record
Andrew D. Weinberg
Also filed as: WEINBERG ANDREW D
8 granted patents·4 pending applications·546 citations·filing 1994–2022
90Inventor score
Files withAGONOX INC2PROVIDENCE HEALTH & SERVICES - OREGON2PROVIDENCE HEALTH SYSTEM2SISTERS OF PROVIDENCE IN OREGO2WEINBERG ANDREW D1
Top patents by PatentIndex Score
12 records- 0197US7622444B2Methods for using OX-40 ligand to enhance an antigen specific immune responseSISTERS OF PROVIDENCE IN OREGO·Filed 2006·Granted Nov 24, 2009·86 cites·11 claims
- 0296US7504101B2Methods for enhancing antigen-specific immune response using antibodies that bind OX-40SISTERS OF PROVIDENCE IN OREGO·Filed 2001·Granted Mar 17, 2009·135 cites·16 claims
- 0393US6312700B1Method for enhancing an antigen specific immune response with OX-40LFiled 1999·Granted Nov 6, 2001·112 cites·23 claims
- 0492US5759546ATreatment of CD4 T-cell mediated conditionsFiled 1994·Granted Jun 2, 1998·104 cites·23 claims
- 0590US7959925B2Trimeric OX40-immunoglobulin fusion protein and methods of usePROVIDENCE HEALTH SYSTEM·Filed 2009·Granted Jun 14, 2011·75 cites·19 claims
- 0676US11572541B2Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancerPROVIDENCE HEALTH & SERVICES—OREGON·Filed 2018·Granted Feb 7, 2023·2 cites·10 claims
- 0774US6566082B1T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditionsFiled 1995·Granted May 20, 2003·32 cites·24 claims
- 0869US12358968B2Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancerPROVIDENCE HEALTH & SERVICES—OREGON·Filed 2022·Granted Jul 15, 2025·0 cites·18 claims
- 0949US2024277842A1Cxcr5, pd-1, and icos expressing tumor reactive cd4 t cells and their useWEINBERG ANDREW D·Filed 2022·Application pending·0 cites
- 1046US2006280728A1Trimeric OX40-immunoglobulin fusion protein and methods of usePROVIDENCE HEALTH SYSTEM·Filed 2006·Application pending·0 cites
- 1138US2022088193A1Anti-CD55 Antibodies and Related Compositions and MethodsAGONOX INC·Filed 2020·Application pending·0 cites
- 1237US2021070858A1CD55-Binding Agent-Related Methods and CompositionsAGONOX INC·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →